Browse > Article
http://dx.doi.org/10.5483/BMBRep.2011.44.11.725

Novel mechanism of a CDH1 splicing mutation in a Korean patient with signet ring cell carcinoma  

Kim, Sol-Lip (Department of Laboratory Medicine, Ilsan Paik Hospital, Inje University College of Medicine)
Ki, Chang-Seok (Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kim, Kyoung-Mee (Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Lee, Myoung-Gun (Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kim, Se-Hwa (Department of Health Science and Technology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Bae, Jae-Moon (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kim, Jong-Won (Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Publication Information
BMB Reports / v.44, no.11, 2011 , pp. 725-729 More about this Journal
Abstract
We report a novel mechanism of a CDH1 splicing mutation in a patient with signet ring cell carcinoma of the stomach. A 27-year-old man complaining of aggravated dyspepsia was diagnosed with signet ring cell carcinoma. Both his father and uncle had died of stomach cancer at a young age. DNA sequencing analysis of the CDH1 gene revealed a splice site mutation (c.833-2A>G). By RNA/cDNA sequencing analysis, CDH1 c.833-2A>G generated a new acceptor site within intron 6, causing the insertion of a 79-bp intronic sequence between exon 6 and 7 (r.833-79_833-1ins), and resulting in a frame shift. E-cadherin immunohistochemical staining revealed a loss of CDH1 expression. This study reveals the disease-causing mechanism of this splicing mutation, and emphasizes the need for functional studies using RNA samples for the accurate interpretation of detected splicing variant. This is the first reported case of a CDH1 mutation in a Korean patient.
Keywords
CDH1; E-cadherin; Hereditary diffuse gastric cancer; Signet ring cell carcinoma; Splicing mutation;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 American Joint Committee in Cancer (2002) AJCC Cancer Staging Manual. 6th ed. Springer, Chicago, Ill., USA.
2 Yoon, K. A., Ku, J. L., Yang, H. K., Kim, W. H., Park, S. Y. and Park, J. G. (1999) Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J. Hum. Genet. 44, 177-180.   DOI
3 Kim, I. J., Kang, H. C., Shin, Y., Park, H. W., Jang, S. G., Han, S. Y., Lim, S. K., Lee, M. R., Chang, H. J., Ku, J. L., Yang, H. K. and Park, J. G. (2004) A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome. J. Hum. Genet. 49, 591-595.   DOI
4 Dicken, B. J., Bigam, D. L., Cass, C., Mackey, J. R., Joy, A. A. and Hamilton, S. M. (2005) Gastric adenocarcinoma: review and considerations for future directions. Ann. Surg. 241, 27-39.
5 Rogers, W. M., Dobo, E., Norton, J. A., Van Dam, J., Jeffrey, R. B., Huntsman, D. G., Kingham, K., Chun, N., Ford, J. M. and Longacre, T. A. (2008) Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Am. J. Surg. Pathol. 32, 799-809.   DOI   ScienceOn
6 Houdayer, C., Dehainault, C., Mattler, C., Michaux, D., Caux-Moncoutier, V., Pages-Berhouet, S., d'Enghien, C. D., Lauge, A., Castera, L., Gauthier-Villars, M. and Stoppa-Lyonnet, D. (2008) Evaluation of in silico splice tools for decision-making in molecular diagnosis. Hum. Mutat. 29, 975-982.   DOI   ScienceOn
7 Pharoah, P. D., Guilford, P. and Caldas, C. (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121, 1348-1353.   DOI   ScienceOn
8 Caldas, C., Carneiro, F., Lynch, H. T., Yokota, J., Wiesner, G. L., Powell, S. M., Lewis, F. R., Huntsman, D. G., Pharoah, P. D., Jankowski, J. A., MacLeod, P., Vogelsang, H., Keller, G., Park, K. G., Richards, F. M., Maher, E. R., Gayther, S. A., Oliveira, C., Grehan, N., Wight, D., Seruca, R., Roviello, F., Ponder, B. A. and Jackson, C. E. (1999) Familial gastric cancer: overview and guidelines for management. J. Med. Genet. 36, 873-880.
9 Ziogas, D. and Roukos, D. H. (2009) CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer? Ann. Surg. Oncol. 16, 2678-2681.   DOI
10 Brooks-Wilson, A. R., Kaurah, P., Suriano, G., Leach, S., Senz, J., Grehan, N., Butterfield, Y. S., Jeyes, J., Schinas, J., Bacani, J., Kelsey, M., Ferreira, P., MacGillivray, B., MacLeod, P., Micek, M., Ford, J., Foulkes, W., Australie, K., Greenberg, C., LaPointe, M., Gilpin, C., Nikkel, S., Gilchrist, D., Hughes, R., Jackson, C. E., Monaghan, K. G., Oliveira, M. J., Seruca, R., Gallinger, S., Caldas, C. and Huntsman, D. (2004) Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J. Med. Genet. 41, 508-517.   DOI
11 Graziano, F., Humar, B. and Guilford, P. (2003) The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann. Oncol. 14, 1705-1713.   DOI   ScienceOn
12 Humar, B. and Guilford, P. (2009) Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci. 100, 1151-1157.   DOI   ScienceOn